Contents I. Introduction
Cancer represents a pervasive global health challenge, necessitating continual advancements in therapeutic modalities [1]. In response, theranostic applications have emerged as a promising approach, seamlessly integrating diagnostic and therapeutic components to provide comprehensive cancer management [2], [3], [4]. Of particular interest are multicompartment nanoparticles (NPs), incorporating magnetic and plasmonic constituents such as gold and iron oxide [5], [6], [7], [8]. Iron oxide facilitates magnetic resonance imaging, while gold enables X-ray attenuation and optical imaging, thereby affording versatile bioimaging and targeted drug delivery strategies. Moreover, these NPs hold the potential for combined magnetic hyperthermia and photothermal therapy, presenting a multifaceted approach to cancer treatment [9], [10]. Within the landscape of NP architectures, heterodimer, and core-shell structures have garnered considerable attention due to their promising applications.
